The DNTT gene helps immature B cells and T cells create diverse receptors that recognize germs by adding extra DNA letters during development. If it does not work well, the immune system may make a narrower set of these receptors, which can reduce how flexibly the body responds to infections. In medicine, this gene is best known because its protein, called TdT, is often used as a lab marker in some leukemias, especially acute lymphoblastic leukemia.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when and where certain activities take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. More information about this topic is available in the LearnHub.
Overview
DNTTGene function
What if the gene works
The DNTT gene helps developing B and T cells create many different immune receptors by adding extra DNA letters. This gives your immune system a broader ability to recognize germs.
Risk
What if the gene does not work
Milder to more severe variants in the DNTT gene can reduce or disrupt a protein that adds extra DNA building blocks while early B cells and T cells form their receptors. This can narrow the range of immune receptors.
Treatment
What does that mean for your treatment
No DNTT-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the DNTT gene. In clinical practice, the DNTT gene is used mainly as a biomarker in some leukemias and lymphomas, and it is being studied more as a disease marker than as a direct treatment target.
Gene function
What if the gene works
The DNTT gene helps your body build a wide range of immune cell receptors early in immune cell development. Its protein adds extra DNA letters while young B cells and T cells are assembling the receptor patterns they will use to spot germs. This step makes each developing immune cell a little different, which supports a broad and flexible immune response.
Its protein adds extra DNA letters at joining points while young B cells and T cells build their receptors. It acts during V(D)J recombination (the gene mixing step that assembles immune receptors).
Those added DNA letters help create many different receptor patterns instead of repeating the same design. This gives the immune system a broader set of ways to recognize infections.
DNTT works mainly in immature B cells and T cells, when their first receptors are being formed. This is how the DNTT gene supports early immune cell development.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the DNTT gene can alter the TdT protein’s shape, stability, or active site, changing how well it adds extra DNA letters during immune cell DNA joining. This is the core of how DNTT gene variants affect protein function: milder variants may partly reduce enzyme activity, while more severe variants can truncate the protein or leave it with little to no activity. As a result, the joining process may become less flexible at the cellular level.
How variants are linked to conditions
The DNTT gene does not yet have a broadly confirmed link to a specific inherited health condition, although research on how DNTT gene variants are linked to conditions is still developing. If you carry a reported variant in the DNTT gene, your doctor or genetic counselor can interpret it in the context of your personal and family history.
A variant is not necessarily a diagnosis
Variants in genes are a common and normal part of human biology across the general population. Most of these variants do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to DNTT. Anyone concerned about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of DNTT variants
There is not yet a broadly confirmed Mendelian pattern for how DNTT gene variants are inherited in relation to a specific inherited condition. Current evidence does not support a single well-established dominant, recessive, or X linked pattern for the DNTT gene. For families trying to understand how DNTT gene variants are inherited, it helps to know that DNTT is located on chromosome 10, which is an autosome. That means each person inherits one copy of the DNTT gene from each parent.
What does my DNTT result mean for my family?
For families with a disease-causing change in the DNTT gene, the pattern is usually recessive, which means close relatives may also be carriers even if they are healthy. Brothers and sisters could also have the condition or be carriers, depending on which gene changes they inherited. This can matter for future pregnancies and for relatives who want to better understand their own chances of carrying the same change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the DNTT gene, genetic testing for DNTT variants usually analyzes DNA from a blood sample or saliva. A lab reads the gene’s sequence and compares it with the usual version, then reports whether a variant is benign, likely pathogenic, pathogenic, or of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established, DNTT-specific reason to get genetic testing. Testing decisions are usually based on the bigger picture, including your personal health history and family history, with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic test result can provide useful insight, but how much it explains depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way medications work. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug acts and how the body handles it. This understanding can support more informed, individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the DNTT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about your health, symptoms, or treatment are best discussed with your doctor.
History
The DNTT gene entered medical research through studies of an unusual DNA building enzyme found in immature immune cells in the 1960s. Researchers later linked this enzyme, called terminal deoxynucleotidyl transferase or TdT, to early blood cell development and to certain leukemias and lymphomas. From these first observations, research expanded steadily, and TdT became a familiar laboratory marker in hematology. As genetic methods improved, scientists identified the DNTT gene as the source of this enzyme and clarified where it is normally active. Its history is closely tied to the rise of modern leukemia classification, when doctors began separating blood cancers by cell type rather than by appearance alone. This work helped move diagnosis toward the more precise methods used today.